Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
Links shared publicly online about this topic.
- 239total visits
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
View full resource at health.yahoo.net
Tags: Cancer, Breast Cancer, Drug, Women's Health, News
Most Recently Shared on June 6, 2011 at 4:27 am By:
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women http://bit.ly/lRQuoZ
Researchers ponder why estrogen-only HRT may reduce breast cancer risk - latimes.com
latimes.com — “A review says that estrogen-only hormone therapy clearly reduces breast cancer risk in postmenopausal women.” View full resource at latimes.com
Most Recently Shared on March 15, 2012 at 10:54 pm By:
Debby Verville Health Advocate
Researchers ponder why estrogen-only HRT may reduce breast cancer risk - http://t.co/nwIFvBld http://t.co/YUnunwSM
Researchers ponder why estrogen-only HRT may reduce breast cancer risk - latimes.com
latimes.com — “A review says that estrogen-only hormone therapy clearly reduces breast cancer risk in postmenopausal women.” View full resource at latimes.com
Most Recently Shared on March 15, 2012 at 9:10 pm By:
Researchers ponder why estrogen-only HRT may reduce breast cancer risk: Breast cancer risk may decline in postme... http://t.co/oMFeM34j
Researchers ponder why estrogen-only HRT may reduce breast cancer risk - latimes.com
latimes.com — “A review says that estrogen-only hormone therapy clearly reduces breast cancer risk in postmenopausal women.” View full resource at latimes.com
Most Recently Shared on March 15, 2012 at 8:25 pm By:
LA Times Health News Health News
Researchers ponder why estrogen-only HRT may reduce breast cancer risk http://t.co/jCaf57mj
Pfizer’s Breast-Cancer Drug Worsens Bone Loss in Older Women - Businessweek
businessweek.com — “Pfizer Inc.’s breast-cancer drug Aromasin worsened bone loss in post-menopausal women, raising the chance of fractures and calling into question whether the pill’s prevention benefits outweigh its risks.” View full resource at businessweek.com
Most Recently Shared on February 11, 2012 at 12:18 am By:
Pfizer’s Breast-Cancer Drug Worsens Bone Loss in Older Women: Pfizer Inc.’s breast-cancer drug Aromasin worsened... http://t.co/Cg0ABRiX
Susan G. Komen for the Cure | Understanding Breast Cancer | Risk Factors and Prevention | Reproductive Risks | Postmenopausal Hormone Use
ww5.komen.org — “How Hormones Affect Breast Cancer PDF, 124KB Postmenopausal hormones have been used by many women to relieve menopausal symptoms and to reduce the risk of certain chronic diseases, most often heart di” View full resource at ww5.komen.org
Most Recently Shared on November 21, 2011 at 8:50 pm By:
Komen for the Cure Health Organization
The study discusses postmenopausal hormones, and you can learn more about that here: http://t.co/rJXM19qo
Breast Cancer Research: Dr. Feldman Explains New Study on Exemestane | Columbia University Department of Surgery Blog
columbiasurgery.net — “As reported in the NYT, the drug exemestane was found to reduce breast cancer occurance in post-menopausal women at high risk of developing breast cancer.” View full resource at columbiasurgery.net
Most Recently Shared on October 20, 2011 at 5:15 pm By:
What is exemestane? How is it used to prevent the?occurrence?of breast cancer in high risk women? http://t.co/S6ydEMcQ
Breast Cancer Recurrences Lower with Letrozole, Updated Data Show - Physician's First Watch
firstwatch.jwatch.org — “A 12-year update of the Breast International Group (BIG) 1-98 trial shows that the aromatase inhibitor letrozole continues to reduce risk for relapse and death in postmenopausal women with early-stage hormone-responsive breast cancer, researchers reported . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on September 26, 2011 at 3:39 pm By:
Arnold Klein Physician, Active Health Library, Doctor, and Dermatologist
http://t.co/nFMeViwQ exciting news for breast cancer treatment
Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast Ca - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Make room, tamoxifen: The aromatase inhibitor exemestane (Aromasin) prevents first breast cancers in moderate- to high-risk postmenopausal women, according to randomized trial results.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:09 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast Ca - http://t.co/azVU6xf from @medpagetoday #health #medicine
Hot Flushed
naturalproductsinsider.com — “Since 37.5 million U.S. women are at or near menopause, and 45.6 million are postmenopausal, according to NAMS; and hormone replacement therapy (HRT) isn’t always an attractive remedy, women are in search of effective remedies that can reduce symptoms and the risk for breast cancer and osteoporosis via natural supplements such as maca, genistein and resveratrol.” View full resource at naturalproductsinsider.com
Most Recently Shared on August 2, 2011 at 10:27 pm By:
Dr. Susan Beck Doctor, CAM, Nutritionist, PhD, and Acupuncturist
How often do you hear yourself asking, "Is it hot in here....?" http://ow.ly/5TCec #menopause #women #health
Exemestane Is a New Option for Prevention of Breast Cancer in Postmenopausal Women
onclive.com — “Postmenopausal women at risk of breast cancer got good news from the MAP.3 trial results: Exemestane reduced their risk of invasive breast cancer by 65% compared with placebo.” View full resource at onclive.com
Most Recently Shared on August 1, 2011 at 6:56 pm By:
Exemestane Is a New Option for Prevention of Breast Cancer in Postmenopausal Women http://t.co/uxaRzGp #breastcancer
Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some - Yahoo! News
news.yahoo.com — “Read 'Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some' on Yahoo! News. THURSDAY, Dec. 9 (HealthDay News) -- In a finding that seems to counter the prevailing wisdom that any form of hormone replacement therapy raises the risk of breast cancer, a new look at some old data suggests that estrogen-only hormone therapy might protect a small subset of postmenopausal women against the disease.” View full resource at news.yahoo.com
Most Recently Shared on July 11, 2011 at 11:53 pm By:
Endocrinology Wisdom OW Health
Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some: THURSDAY, Dec. 9 (HealthDay News) -- In a... http://yhoo.it/nD7QS2
Exemestane for Breast-Cancer Prevention in Postmenopausal Women - OncologySTAT
oncologystat.com — “N Engl J Med. 2011 Jun 23;3642381-2391 - PE Goss, JN Ingle, JE Alés-Martínez, AM Cheung, RT Chlebowski, J Wactawski-Wende, A McTiernan, J Robbins, KC Johnson, LW Martin, E Winquist, GE Sarto, JE Garber, CJ Fabian” View full resource at oncologystat.com
Most Recently Shared on July 6, 2011 at 4:02 pm By:
OncologySTAT Oncology and Health Site
Story of the Week With Expert Commentary: Exemestane Reduces Risk of Invasive Breast Cancer http://t.co/QHoe6Bo
Susan G. Komen for the Cure | Aromasin Reduces Breast Cancer Risk in High-risk Women
ww5.komen.org — “Susan G. Komen for the Cure | Aromasin Reduces Breast Cancer Risk in High-risk Women” View full resource at ww5.komen.org
Most Recently Shared on June 7, 2011 at 5:50 pm By:
Komen for the Cure Health Organization
Interesting article from @komenforthecure about reducing breast cancer risk in high-risk women. http://bit.ly/ldU4nB #breastcancerrisk
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews
drugs.com — “The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found. And unlike oth” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 1:32 am By:
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - http://bit.ly/j8vbsn
Advertisement
